26 51

Cited 0 times in

신이식환자에서 Prednisone과 Deflazacort의 골대사 , 면역억제능 그리고 당대사 능력의 비교에 관한 전향적 연구 - 골밀도와 면역억제능에 미치는 영향을 중심으로 -

Other Titles
 Is There any Positive Impact on the Bone Mineral Density If We Switch Prednisone to Deflazacort during the Maintenance Phase of Immunosuppression in Renal Transplant recipients ? 
 김명수  ;  문상원  ;  김유선  ;  이은미  ;  오창권  ;  정구용  ;  임승길  ;  김택균  ;  김순일  ;  박기일  ;  김영수 
 Journal of the Korean Society for Transplantation (대한이식학회지), Vol.10(1) : 179-186, 1996-12 
Journal Title
Journal of the Korean Society for Transplantation(대한이식학회지)
Issue Date
Kidney transplant recipients are exposed to the multiple factors that lead to the osteoporosis. The corticosteroid is mainly responsihle to the post-transplant osteoporosis. The clinical trial of deflazacort with biologically equivalent dose of conventional corticosteroid revealed less detrimental effect on the bone metabolism. We tried elective conversion from prednisone to deflazacort in recipient with stable graft function after more than post-transplant 1 year. Sixteen recipients were converted from prednisone to deflazacort as the conversion group and 20 recipients maintained on prednisone as the control group. In both groups, 2 imes of bone densitometry(BDM) test were taken at the time of study entry and susequently 1 year later respectively. There was no significant difference in terms of BDM activity in both groups. In the control group, the activity of BMD, T-score and Z-score of spine or femur neck did not change during the study period significantly. We could not find any bone sparing effect after deflazacort conversion. The biochemical markers for bone metabolism, such as serum osteocalcin, urinary deoxypyridinoline and 24hrs urinary excretion of calcium also did not improve even after deflazacort conversion. Although the body weight reduction in the conversion group was significant compared with the control group, the serum lipid profiles were not changed. The acute or chronic episodes of rejection did not occur during the study period in the conversion group. In conclusion, elective deflazacort conversion in long-term renal allograft survivors with maintenance immunosuppression has no positive impact on the bone mineral metabolism at least during the short-term follow-up.
Files in This Item:
T199601999.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Yu Seun(김유선) ORCID logo https://orcid.org/0000-0002-5105-1567
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.